bioAffinity Technologies (BIAF) vs ICON (ICLR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
ICON is the larger company by market cap ($12.67 billion vs $5.5 million), about 2297.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIAF | ICLR |
|---|---|---|
| Share price | $4.73 | $164.17 |
| Market cap | $5.51M | $12.67B |
| 1-day change | -16.22% | -0.20% |
| YTD return | — | -9.72% |
| 1-year return | — | -11.79% |
| 5-year return | — | -40.19% |
| P/E ratio (TTM) | — | 172.81 |
| Forward P/E | — | 13.92 |
| EPS (TTM) | $-109.35 | $0.95 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $8.25B |
| Revenue growth (YoY) | — | +0.76% |
| Net income (latest FY) | — | $229.34M |
| Gross margin | — | 26.37% |
| Operating margin | — | 5.37% |
| Net margin | — | 2.78% |
| 52-week high | $80.70 | $203.91 |
| 52-week low | $4.56 | $66.57 |
| Distance from 52-week high | -94.14% | -19.49% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +12.33% |
| Average volume | 3.67M | 822.57K |
| Shares outstanding | 1.17M | 77.15M |
| Employees | 57 | 40,200 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Commercial Physical & Biological Resarch |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ICON is about 2297.8 times larger than bioAffinity Technologies by market value ($12.67B vs $5.51M).
About bioAffinity Technologies
BIAF stock →bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 57 employees
About ICON
ICLR stock →ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 40,200 employees
BIAF vs ICLR FAQ
Which is bigger, bioAffinity Technologies or ICON?
ICON (ICLR) is larger, with a market capitalization of $12.67B compared with $5.51M for bioAffinity Technologies (BIAF).
Are bioAffinity Technologies and ICON in the same industry?
Yes. Both are classified in the Biotechnology: Commercial Physical & Biological Resarch industry within the Health Care sector.